In the most recent trading session, AbbVie (ABBV) closed at $171.63, indicating a -1% shift from the previous trading day.
Vous n'êtes pas connecté
AbbVie is set to acquire privately held biotech, Nimble Therapeutics, for $200 million to strengthen its immunology pipeline.
In the most recent trading session, AbbVie (ABBV) closed at $171.63, indicating a -1% shift from the previous trading day.
In the most recent trading session, AbbVie (ABBV) closed at $171.63, indicating a -1% shift from the previous trading day.
Novolex will acquire Pactiv Evergreen for USD 6.7 billion. Upon the completion of the transaction, Pactiv Evergreen will become a privately held...
KNF inks a deal to acquire Strata for $454 million, boosting its Central Segment and supporting long-term growth.
KNF inks a deal to acquire Strata for $454 million, boosting its Central Segment and supporting long-term growth.
On Semiconductor is set to acquire SiC JFET tech from Qorvo for $115M, enhancing its EliteSiC portfolio to drive energy efficiency in AI data centers...
EXP set to benefit from the expansion of its product portfolio and market reach after completing the buyout of Bullskin Stone & Lime.
In a significant move within the cybersecurity industry, Arctic Wolf recently announced its acquisition of the Cylance endpoint security assets from...
The Netherlands and its partners have invested over €200 million in the Tallinn Mechanism, the main task of which is to strengthen Ukraine's...
The Netherlands and its partners have invested over €200 million in the Tallinn Mechanism, the main task of which is to strengthen Ukraine's...